Kozak & Associates, Inc. - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 34 filers reported holding VIVOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kozak & Associates, Inc. ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$335
-44.4%
1,2050.0%0.00%
Q2 2023$602
+46.5%
1,2050.0%0.00%
Q1 2023$4111,2050.0%0.00%
Q4 2022$0
-100.0%
1,2050.0%0.00%
-100.0%
Q3 2022$1,000
-50.0%
1,2050.0%0.00%0.0%
Q2 2022$2,000
-50.0%
1,2050.0%0.00%
-66.7%
Q1 2022$4,0000.0%1,2050.0%0.00%0.0%
Q4 2021$4,000
-20.0%
1,2050.0%0.00%0.0%
Q3 2021$5,0001,2050.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 3,219,705$618,5050.11%
PERKINS CAPITAL MANAGEMENT INC 15,000$30.00%
Apexium Financial, LP 40,667$7,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 213$410.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$38,7920.00%
STATE STREET CORP 45,650$8,7690.00%
MORGAN STANLEY 1,667$3200.00%
BlackRock Inc. 1,037$1990.00%
LPL Financial LLC 35,484$6,8160.00%
View complete list of VIVOS THERAPEUTICS INC shareholders